Procurement of Oncology Chemotherapy Drugs for Indian Army Healthcare

This tender, identified by Bid Number GEM/2026/B/8009412, is issued by the Department of Military Affairs, under the Ministry of Defence, on behalf of the Indian Army. The procurement concerns a vital supply of "ONCO CHEMO DRUGS" with a total quantity of 3489 units. The bidding period commences on October 22, 2026, at 12:23 PM and concludes on November 5, 2026, at 1:00 PM. The specific item categories required encompass a comprehensive list of oncology medications, including but not limited to Crizotinib 250 MG Injection, Bevacizumab 300 mg, Brentuximab Vedotin 50 MGVAIL Injection, Cetuximab 100mg Injection, Nano particle paclitaxel polymer base 300mg Injection, Phesgo subcutaneous pertuzumab 600mg PLUS Trastuzumab 600mg with hyaluronidase Injection, Phesgo subcutaneous pertuzumab 1200mg PLUS Trastuzumab 600mg with hyaluronidase Injection, Ramucirumab 500mg/50ml vial Injection, Abemaciclib 200 mg Tablets, Capmatinib 200mg Tablets, Ceritinib 150mg tablets, Tepotinib 225 mg Tablets, Pegylated Liposomal irinotecan 4.3 mg/ml concentrate for dispersion for infusion, Serplulimab 100mg Injection, Toripalimab 240mg Injection, Tremelimumab 300mg Injection, Enfortumab vedotin 30mg Injection, Enfortumab vedotin 20mg Injection, Nimotuzumab 50 mg Injection, Enzalutamide 160mg Tablets, Palonosetron 0.25mg Injection, and Leuprolide 11.25mg Injection. This crucial tender, originating from Panchkula, seeks qualified suppliers to provide these essential oncological treatments to support the healthcare needs of the Indian Army.